skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 50  for All Library Resources

Results 1 2 3 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

2
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article
Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

3
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Material Type:
Article
Add to My Research

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

New England Journal of Medicine, 2022-01, Vol.386 (4), p.340-350 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2115481 ;PMID: 35021002

Digital Resources/Online E-Resources

4
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Material Type:
Article
Add to My Research

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

Nature communications, 2021-12, Vol.12 (1), p.7217-7217, Article 7217 [Peer Reviewed Journal]

2021. Crown. ;Crown 2021. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2021, corrected publication 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27410-5 ;PMID: 34893611

Full text available

5
Impact of the COVID-19 pandemic on Bordetella pertussis infections in England
Material Type:
Article
Add to My Research

Impact of the COVID-19 pandemic on Bordetella pertussis infections in England

BMC public health, 2022-02, Vol.22 (1), p.405-405, Article 405 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2458 ;EISSN: 1471-2458 ;DOI: 10.1186/s12889-022-12830-9 ;PMID: 35220973

Full text available

6
Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data
Material Type:
Article
Add to My Research

Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data

PLoS medicine, 2022-02, Vol.19 (2), p.e1003916-e1003916 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 McQuaid et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 McQuaid et al 2022 McQuaid et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003916 ;PMID: 35192611

Full text available

7
Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking
Material Type:
Article
Add to My Research

Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking

Nature communications, 2023-07, Vol.14 (1), p.3984-3984, Article 3984 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-39674-0 ;PMID: 37414791

Full text available

8
Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Material Type:
Article
Add to My Research

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

Nature communications, 2022-02, Vol.13 (1), p.733-733, Article 733 [Peer Reviewed Journal]

Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-28393-7 ;PMID: 35110555

Full text available

9
Variation in reported SARS-CoV-2 cases after testing policy changes
Material Type:
Article
Add to My Research

Variation in reported SARS-CoV-2 cases after testing policy changes

The Lancet infectious diseases, 2022-10, Vol.22 (10), p.1418-1419 [Peer Reviewed Journal]

Copyright Elsevier Limited Oct 2022 ;Crown Copyright © 2022 Published by Elsevier Ltd. All rights reserved. 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00572-2 ;PMID: 36027903

Full text available

10
Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years
Material Type:
Article
Add to My Research

Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years

Clinical infectious diseases, 2024-02, Vol.78 (2), p.349 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab881 ;PMID: 37758203

Digital Resources/Online E-Resources

11
Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020
Material Type:
Article
Add to My Research

Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020

Euro surveillance : bulletin européen sur les maladies transmissibles, 2020-05, Vol.25 (19), p.7 [Peer Reviewed Journal]

Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) May 14, 2020 ;This article is copyright of the authors or their affiliated institutions, 2020. 2020 The authors or their affiliated institutions ;ISSN: 1560-7917 ;ISSN: 1025-496X ;EISSN: 1560-7917 ;DOI: 10.2807/1560-7917.ES.2020.25.19.2000848 ;PMID: 32431288

Full text available

12
Optimization of Timing of Maternal Pertussis Immunization From 6 Years of Postimplementation Surveillance Data in England
Material Type:
Article
Add to My Research

Optimization of Timing of Maternal Pertussis Immunization From 6 Years of Postimplementation Surveillance Data in England

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e1129-e1139 [Peer Reviewed Journal]

Crown copyright 2022. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciac651 ;PMID: 35959786

Full text available

13
Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012–2018
Material Type:
Article
Add to My Research

Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012–2018

Vaccine, 2022-01, Vol.40 (3), p.444-449 [Peer Reviewed Journal]

2021 ;Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 24, 2022 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.12.011 ;PMID: 34955326

Full text available

14
How data from the United Kingdom has guided covid-19 vaccine policies
Material Type:
Article
Add to My Research

How data from the United Kingdom has guided covid-19 vaccine policies

BMJ (Online), 2022-03, Vol.376, p.o839-o839 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2022BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.o839 ;PMID: 35354582

Full text available

15
Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls
Material Type:
Article
Add to My Research

Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e962-e973 [Peer Reviewed Journal]

Crown copyright 2022. 2022 ;Crown copyright 2022. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciac151 ;PMID: 35245941

Full text available

16
Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
Material Type:
Article
Add to My Research

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e2502-e2508 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa836 ;PMID: 32569365

Full text available

17
Equity of the Meningitis B vaccination programme in England, 2016–2018
Material Type:
Article
Add to My Research

Equity of the Meningitis B vaccination programme in England, 2016–2018

Vaccine, 2022-10, Vol.40 (42), p.6125-6132 [Peer Reviewed Journal]

2022 ;Copyright Elsevier Limited Oct 6, 2022 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2022.09.023

Full text available

18
Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19
Material Type:
Article
Add to My Research

Making the invisible visible: using national surveillance data to identify people experiencing homelessness in England with COVID-19

Epidemiology and infection, 2023-02, Vol.151, p.e51-e51, Article e51 [Peer Reviewed Journal]

Copyright © Crown Copyright – UK Health Security Agency, 2023. Published by Cambridge University Press ;Copyright © Crown Copyright – UK Health Security Agency, 2023. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0950-2688 ;EISSN: 1469-4409 ;DOI: 10.1017/S095026882300033X ;PMID: 36852580

Full text available

19
Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking
Material Type:
Article
Add to My Research

Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking

Nature communications, 2023-07, Vol.14 (1) [Peer Reviewed Journal]

cc_by_4 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-39674-0

Full text available

20
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria
Material Type:
Article
Add to My Research

Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria

Vaccine, 2023-08, Vol.41 (36), p.5330-5337 [Peer Reviewed Journal]

2023 ;Copyright © 2023. Published by Elsevier Ltd. ;Copyright Elsevier Limited Aug 14, 2023 ;2023 Published by Elsevier Ltd. 2023 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2023.06.006 ;PMID: 37495490

Full text available

Results 1 - 20 of 50  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2005  (1)
  2. 2005 To 2017  (1)
  3. 2018 To 2018  (3)
  4. 2019 To 2020  (8)
  5. After 2020  (38)
  6. More options open sub menu

Resource Type 

  1. Articles  (49)
  2. Reports  (1)
  3. More options open sub menu

Language 

  1. Japanese  (3)
  2. French  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait